The provided text consists of excerpts from a Boston Scientific presentation detailing their Q3 2025 financial and operational highlights. The document explicitly states that it contains forward-looking statements and utilizes non-GAAP financial measures, which are thoroughly reconciled in the appendices. Key financial data includes reported net sales of $5.065 billion and a 20.3% reported net sales growth year-over-year. The presentation outlines performance across major segments like Cardiovascular and MedSurg, noting significant growth in areas like Electrophysiology and WATCHMAN. Furthermore, it mentions important operational updates, such as PMDA approval in Japan for the FARAPULSE™ PFA System and several recent acquisitions and clinical trial enrollments.
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
3ª PARTE | 17 DIC 2025 | EL PARTIDAZO DE COPE
01 Jan 1970
El Partidazo de COPE
13:00H | 21 DIC 2025 | Fin de Semana
01 Jan 1970
Fin de Semana
12:00H | 21 DIC 2025 | Fin de Semana
01 Jan 1970
Fin de Semana
10:00H | 21 DIC 2025 | Fin de Semana
01 Jan 1970
Fin de Semana
13:00H | 20 DIC 2025 | Fin de Semana
01 Jan 1970
Fin de Semana
12:00H | 20 DIC 2025 | Fin de Semana
01 Jan 1970
Fin de Semana